top of page

GLOBAL DEAL SYNDICATION

HBS Alumni Angels syndicates selected deals across the full global membership of its 14 chapters. This enables selected deals from one chapter to reach a global network of accredited investor alumni. This is a unique benefit of being a member in a local HBS Alumni Angel chapter. Investment decisions are made and executed individually following a global webinar. Once investments are made, investors often assist companies in other areas as formal or informal advisers. For details on how the process works, please scroll down.

UPCOMING SYNDICATION CALLS

SAVE THE DATE

20250605 Moxie Scrubs logo.png

GLOBAL SYNDICATED INVESTMENT PRESENTATION:
MOXIE SCRUBS

SAVE THE DATE
 
Thursday, June 5, 2025 9am PT, 12pm ET, 5pm London, 6pm Continental Europe

Presenter:
CEO & Founder, Alicia Tulsee, MBA'15
​
For HBS Angels Members ONLY

 

On behalf of the Boston chapter, we would like to share the following investment opportunity:

​

The first and only brand inspired and designed by nurses, Moxie Scrubs is proud to be a woman-owned, minority-owned Boston-based start-up, born in a taxi cab and Harvard’s Innovation Lab.

 

MORE INFORMATION COMING SOON!

​

Alicia Tulsee

FOUNDER & CEO, HBS MBA 2015

20250605 Alicia Tulsee.jpg

Alicia Tulsee is a native New Yorker and Harvard alum based in Boston, MA and is the founder of the first direct to consumer medical apparel brand for nurses, Moxie Scrubs. Alicia graduated from Harvard University with a degree in economics in 2015 and has expertise in consumer packaged goods, entertainment, and nonprofits. Alicia previously spearheaded national marketing for brands like Budweiser and AB InBev portfolio brands in emerging markets, FreshPure Waters, and others. In the music industry, Alicia worked in event planning and management, copy-writing, working directly with artists.

In awe of all of the amazing nurses who cared for her loved ones, Alicia felt a calling to do something meaningful for the nursing profession and founded Moxie Scrubs out of Harvard University’s Innovation Lab with the passion to create a brand dedicated to giving nurses the sense of fashion, professionalism, and respect that they want and deserve.

Today, Alicia has received acclaim as an impact entrepreneur in Forbes, ForbesWomen, Nasdaq, Entrepreneur Magazine, and others.

REGISTRATION

The Zoom Meeting information will be in your registration confirmation email.
Please check your junk/spam/bulk folders if you don't see it.

PREVIOUS SYNDICATION CALL

20250410 Osteoboost.png

GLOBAL SYNDICATED INVESTMENT PRESENTATION:
OSTEOBOOST

Thursday, April 10, 2025 9am PT, 12pm ET, 5pm London, 6pm Continental Europe

Presenter:
CEO & President, Laura Yecies, MBA'88
​
For HBS Angels Members ONLY

 

On behalf of the New York chapter, we would like to share the following investment opportunity:

​

Osteoboost is a precision vibration therapy medical device, clinically-proven to slow the loss of bone density and strength in postmenopausal women with osteopenia.  Osteoboost is the first FDA-cleared prescription non-drug treatment for low bone density.

 

Company Overview:

At Osteoboost Health, we develop breakthrough solutions to help people defend against osteoporosis and osteopenia. Our mission is simple: to empower people to lead longer, stronger, and more active lives by safeguarding bone density from the effects of menopause, aging, cancer, and other degenerative causes of bone loss.

 

Our flagship product, Osteoboost, is a new way of thinking about an age-old problem: low bone density. It’s a prescription medical device, worn around the hips, that delivers clinically-proven targeted vibration therapy directly to the areas of the body most at risk of life-altering osteoporotic fractures.   Osteoboost includes a comprehensive digital solution, including the recently acquired Wellen osteoporosis exercise program.

 

Osteoboost is an FDA-cleared treatment indicated for postmenopausal women with osteopenia. It fills a critical vacuum in the low bone density treatment and prevention space, and is drug-free, pain-free, and convenient for patients to use in their daily life.

​

Efficacy: 

In a gold-standard double-blinded sham-controlled clinical trial at the University of Nebraska Medical Center, Osteoboost reduced the loss of bone strength in the vertebral spine by 83%, reduced the loss of bone density in the spine by 85%, and reduced the loss of bone density in the hips by 55%. The FDA cleared Osteoboost as a Class II Breakthrough Device through the De Novo pathway in 2024.

 

Sales Highlights To Date: 

In November of 2024, we opened pre-orders to our waiting list, selling >1000 devices for over $1M in collected revenue. Over 950 unique medical providers have prescribed Osteoboost, some as many as 37 times (in 4 months) and physicians from more than 30 leading academic medical centers have prescribed. Osteoboost is expected to launch publicly in mid-April, 2025.

​

Financial and Business Projections:

$5M revenue 2025

$24M revenue 2026

$62M revenue, cash flow positive 2027.

 

Executive Team:

Our executive team offers deep business, scientific, and medical experience

  • CEO: Laura Yecies, MBA from Harvard, MSFS Georgetown

  • Chief Scientific Officer: Michael Jaasma, PhD in orthopedic biomechanics, UC Berkeley

  • Chief Medical Officer: Dr. Pamela Peeke, MD, MPH, FACP, FACSM, UC Berkeley, UC Davis

 

Raise : 

$3.5M SAFE, 20% Discount, $35M Post Money CAP. We have raised $2.8M closed.

Laura Yecies

CO-FOUNDER & CEO, HBS MBA 1988

20250410 Laura Yecies 2.jpg

​Osteoboost CEO Laura Yecies is a healthtech leader and strategist with deep experience launching and scaling medical device and diagnostic companies. Prior to Osteoboost, she was CEO of NeuroSync, Catch (acq. by Apple), and SugarSync (acq J2Global). She holds an MBA from Harvard, MSFS from Georgetown, and AB from Dartmouth. Yecies is a highly-regarded speaker, podcaster, and writer on healthcare and technology.

PAST SYNDICATED COMPANIES

20250410 Osteoboost
20250116 Soteri Skin logo
20241121 VonVascular_Logo_Color
20241117 SUNRAYscientific-NewLogo
20240919 pathotrak
20240905 SYND CO2_Split 1280 × 720
20210614 MomiBaby logo cropped
20221117 Agile Devices HIRES_edited
20240229 WURQ Logo1
20240201 Nuvio Mobility
20231219 pente_logo
20221011 Moxie_Scrubs_Logo NEW_edited
20230727 Mercator logo
20230715 Fuego logo
20230323 Measure Studio logo hi-res 300X90
20230126 Avadain Logo tm
20210614 MomiBaby logo cropped
20221201 EarthGrid_COLOR 200X50
20221117 Agile Devices HIRES_edited
20221110 Epilogue Systems logo
20221011 Moxie_Scrubs_Logo NEW_edited
20220922 TANG app 400X210
20220908 Beckon-FullLogo 400X252
20220531 SurgiBox logo 200X133
20220523 Alleviate-Therapy 200X
20220425 egs-logo
20220413 Eunimart logo 300X
20220201 Lingrove
20210906 Moxie_Scrubs_Logo 500X135
20210819 Landsdowne Labs
20210722 RocketStar
20210614 MomiBaby logo cropped
20210527 Cognoptix logo 200X36
20210427 Synd Call LUPII_LOGO 200X
20210121 TANG app 2 150X
20201209 Wave logo 200X
20201203 Beckon logo
20201119%20Syndication%20Dover%20Microsy
20200826 New View logo
20200813%2520COLORONLY%2520logo_edited_e
20200811 BrightSpec Logo
unnamed
Wheeli
Vaporox
Cargo Chief
MyndBlue
Health Hero
agencyQ
HIPAAtrek
IrriGreen
SIA
Tire Agent
Wibmo

HOW IT WORKS

Use arrows on the side to navigate

1. HOST CHAPTER

A company must meet a threshold of member investment in one of our HBS Alumni Angel Chapters listed here. The leadership of the host chapter nominates the company for global syndication and provides a local member contact to act as syndication lead and a company contact.

CRITERIA

Ideally, for global syndication a company should meet the following requirements:

  • Local host chapter members committed to invest at least $50,000* and local chapter forwards deal to global for syndication; 

  • Company assures at least $50,000-100,000 investible capacity;

  • Company provides at least 2 weeks for due diligence following the webinar, prior to requiring an investment decision;

  • Minimum individual investment amount is set at $25,000 or less;

  • Company agrees to a one-time admin fee of $1500.

The Global Syndication Committee selects the most suitable company candidates from the 15 participating HBSAA chapters and is aiming to host monthly webinars. 

​

*NY and other larger chapters may have a $100,000 min.

HBS Alumni Angels Association
© Copyright HBS Alumni Angels Association
ALL RIGHTS RESERVED.

  • Instagram
  • Facebook - Black Circle
  • Twitter - Black Circle
  • LinkedIn - Black Circle
bottom of page